Multidisciplinary intervention for treatment of benign joint hypermobility syndrome in childhood

The efficacy and cost effectiveness of a multidisciplinary intervention strategy for the treatment of benign joint hypermobility syndrome in childhood

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN86573140

Enrollment

120

Registered

2017-03-09

Start date

2010-10-21

Completion date

Unknown

Last updated

2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign joint hypermobility syndrome Musculoskeletal Diseases

Interventions

Those consenting to take part will be invited for a screening assessment undertaken by the trial physiotherapist to identify their eligibility for inclusion. Written consent will be sought from eligib

a programme of 6 physiotherapy sessions to improve core stability and work on strengthening exercises

gait analysis and provision of foot orthoses as necessary

an OT assessment at hospital clinic and at home with provision of appliances as necessary

an OT school visit to discuss diagnosis with teachers and provide appliances as necessary. Those with problems in their hands will also receive an OT directed exercise programme. The

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Children aged between 5-16 years old 2. Satisfy the Brighton criteria for classification of BJS 3. Reporting musculoskeletal pain in one or more areas of the body for a duration of greater than three months 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Inflammatory joint disease 2. Identifiable heritable disorder of connective tissue 3. Presence of other chronic illness

Design outcomes

Primary

Measure	Time frame
Level of pain and physical functioning, assessed by the Childhood Health Assessment Questionnaire (CHAQ) at baseline, 3 months and 12 months	—

Secondary

Measure	Time frame
Measured at baseline, 3 months and 12 months: 1. Health-related quality of life, assessed using the CHU 9D (9 dimensional Child Health Utility) 2. Number of primary care and hospital attendances and school attendance, measured using the BJH resource use questionnaire 3. Grip strength, assessed using a hand-held dynamometer 4. Pain, assessed using the VAS/Faces Pain Score 5. Function and gross and fine motor skills, assessed using the Movement Assessment Battery for Children 6. Participation in sport, measured using a questionnaire	—

Measure

Time frame

Measured at baseline, 3 months and 12 months: 1. Health-related quality of life, assessed using the CHU 9D (9 dimensional Child Health Utility) 2. Number of primary care and hospital attendances and school attendance, measured using the BJH resource use questionnaire 3. Grip strength, assessed using a hand-held dynamometer 4. Pain, assessed using the VAS/Faces Pain Score 5. Function and gross and fine motor skills, assessed using the Movement Assessment Battery for Children 6. Participation in sport, measured using a questionnaire

—

Countries

United Kingdom

Contacts

Public ContactAlexander Macgregor

a.macgregor@uea.ac.uk+44 (0)160 359 3570

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 22, 2026